{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:03:27Z","timestamp":1768734207606,"version":"3.49.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1097\/md.0000000000011677","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T20:52:58Z","timestamp":1533243178000},"page":"e11677","source":"Crossref","is-referenced-by-count":11,"title":["Role of TNFRSF1A and TNFRSF1B polymorphisms in susceptibility, severity, and therapeutic efficacy of etanercept in human leukocyte antigen-B27-positive Chinese Han patients with ankylosing spondylitis"],"prefix":"10.1097","volume":"97","author":[{"given":"Wang","family":"Xing-rong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Sheng-qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Fa-ming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Jian-hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-69-20210226","first-page":"126","article-title":"A clinical comparison between males and females with ankylosing spondylitis","volume":"12","author":"Gran","year":"1985","journal-title":"J Rheumatol"},{"key":"R2-69-20210226","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrrheum.2012.41","article-title":"Genetics of spondyloarthritis\u2014beyond the MHC","volume":"8","author":"Reveille","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R3-69-20210226","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12041-008-0010-x","article-title":"Novel non-HLA-susceptible regions determined by meta-analysis of four genomewide scans for ankylosing spondylitis","volume":"87","author":"Huang","year":"2008","journal-title":"J Genet"},{"key":"R4-69-20210226","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/03009742.2012.735700","article-title":"Serum levels of IL-33 and its receptor ST2 are elevated in patients with ankylosing spondylitis","volume":"42","author":"Li","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"R5-69-20210226","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3109\/03009742.2014.882408","article-title":"Single nucleotide polymorphisms of the interleukin-33 (IL-33) gene are associated with ankylosing spondylitis in Chinese individuals: a case-control pilot study","volume":"43","author":"Fan","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"R6-69-20210226","first-page":"124","article-title":"Association of IL-1F7 gene with susceptibility to human leukocyte antigen-B27 positive Ankylosing spondylitis in Han Chinese population","volume":"411","author":"Faming Pan","year":"2015","journal-title":"Clin Chim Acta"},{"key":"R7-69-20210226","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","article-title":"The tumor necrosis factor ligand and receptor families","volume":"334","author":"Bazzoni","year":"1996","journal-title":"N Engl J Med"},{"key":"R8-69-20210226","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1186\/ar1816","article-title":"Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis","volume":"7","author":"Glossop","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R9-69-20210226","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/03009740802537684","article-title":"Association between ankylosing spondylitis and polymorphism of tumour necrosis factor receptor II in Taiwanese patients","volume":"38","author":"Tung","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"R10-69-20210226","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00296-011-1997-5","article-title":"\u2212383 A\/C tumor necrosis factor receptor 1 polymorphism and ankylosing spondylitis in Mexicans: a preliminary study","volume":"32","author":"Corona-Sanchez","year":"2012","journal-title":"Rheumatol Int"},{"key":"R11-69-20210226","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jbspin.2012.02.003","article-title":"Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis","volume":"79","author":"Morales-Lara","year":"2012","journal-title":"Joint Bone Spine"},{"key":"R12-69-20210226","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2036.2008.03630.x","article-title":"Genetic polymorphisms of tumour necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn's disease","volume":"27","author":"Matsukura","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-69-20210226","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00403-014-1533-z","article-title":"The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients","volume":"307","author":"Gonzalez-Lara","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"R14-69-20210226","first-page":"958","article-title":"Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA","volume":"27","author":"Pavelka","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"R15-69-20210226","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12891-015-0489-2","article-title":"Efficacy of anti-tumor necrosis factor therapy for extra-articular manifestations in patients with ankylosing spondylitis: a meta-analysis","volume":"16","author":"Wu","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"R16-69-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11280","article-title":"Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation","volume":"11","author":"McLeod","year":"2007","journal-title":"Health Technol Assess"},{"key":"R17-69-20210226","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/kel175","article-title":"The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients","volume":"46","author":"Seitz","year":"2007","journal-title":"Rheumatology (Oxford"},{"key":"R18-69-20210226","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2217\/pgs.15.90","article-title":"Association between TNF-\u03b1 (\u2212308 A\/G, \u2212238 A\/G, \u2212857 C\/T) polymorphisms and responsiveness to TNF-\u03b1 blockers in spondyloarthropathy, psoriasis and Crohn's disease: a meta-analysis","volume":"16","author":"Song","year":"2015","journal-title":"Pharmacogenomics"},{"key":"R19-69-20210226","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3899\/jrheum.131315","article-title":"Tumor necrosis factor-alpha promoter -308\/238 polymorphism association with less severe disease in ankylosing spondylitis is unrelated to serum TNF-alpha and does not predict TNF inhibitor response","volume":"41","author":"Nossent","year":"2014","journal-title":"J Rheumatol"},{"key":"R20-69-20210226","doi-asserted-by":"crossref","first-page":"e104525","DOI":"10.1371\/journal.pone.0104525","article-title":"rs10865331 associated with susceptibility and disease severity of ankylosing spondylitis in a Taiwanese population","volume":"9","author":"Wen","year":"2014","journal-title":"PLoS One"},{"key":"R21-69-20210226","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"R22-69-20210226","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"R23-69-20210226","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"R24-69-20210226","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R25-69-20210226","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cca.2009.10.014","article-title":"Association of IL-1F7 gene with susceptibility to human leukocyte antigen-B27 positive ankylosing spondylitis in Han Chinese population","volume":"411","author":"Pan","year":"2010","journal-title":"Clin Chim Acta"},{"key":"R26-69-20210226","first-page":"1406","article-title":"No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis","volume":"30","author":"Glossop","year":"2003","journal-title":"J Rheumatol"},{"key":"R27-69-20210226","first-page":"316","article-title":"Predictors of longterm outcome in ankylosing spondylitis","volume":"30","author":"Doran","year":"2003","journal-title":"J Rheumatol"},{"key":"R28-69-20210226","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10067-010-1665-2","article-title":"Predictors of radiographic severity and functional disability in Turkish patients with ankylosing spondylitis","volume":"30","author":"Cansu","year":"2011","journal-title":"Clin Rheumatol"},{"key":"R29-69-20210226","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A","article-title":"Is disease severity in ankylosing spondylitis genetically determined?","volume":"44","author":"Hamersma","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R30-69-20210226","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/ard.2003.016386","article-title":"Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis","volume":"63","author":"Rudwaleit","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R31-69-20210226","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00296-008-0552-5","article-title":"Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFalpha therapy in rheumatoid arthritis?","volume":"28","author":"Ongaro","year":"2008","journal-title":"Rheumatol Int"},{"key":"R32-69-20210226","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.humimm.2004.06.010","article-title":"Relationship between the tumor necrosis factor receptor II (TNF-RII) gene polymorphism and sTNF-RII plasma levels in healthy controls and in rheumatoid arthritis","volume":"65","author":"Tolusso","year":"2004","journal-title":"Hum Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000011677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:19:11Z","timestamp":1620962351000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201808030-00069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":32,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000011677","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}